Scott C Weaver Selected Research

Venezuelan Equine Encephalomyelitis

9/2020	Rationally Attenuated Vaccines for Venezuelan Equine Encephalitis Protect Against Epidemic Strains with a Single Dose.
1/2020	Venezuelan equine encephalitis vaccine with rearranged genome resists reversion and protects non-human primates from viremia after aerosol challenge.
1/2018	Novel Insect-Specific Eilat Virus-Based Chimeric Vaccine Candidates Provide Durable, Mono- and Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
10/2016	SEROSURVEY OF SELECTED ARBOVIRAL PATHOGENS IN FREE-RANGING, TWO-TOED SLOTHS (CHOLOEPUS HOFFMANNI) AND THREE-TOED SLOTHS (BRADYPUS VARIEGATUS) IN COSTA RICA, 2005-07.
4/2015	IFIT1 Differentially Interferes with Translation and Replication of Alphavirus Genomes and Promotes Induction of Type I Interferon.
3/2013	IRES-based Venezuelan equine encephalitis vaccine candidate elicits protective immunity in mice.
11/2009	Vaccines for Venezuelan equine encephalitis.
9/2008	Chimeric alphavirus vaccine candidates for chikungunya.
6/2005	A novel, rapid assay for detection and differentiation of serotype-specific antibodies to Venezuelan equine encephalitis complex alphaviruses.
8/2004	Venezuelan equine encephalitis emergence: enhanced vector infection from a single amino acid substitution in the envelope glycoprotein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Scott C Weaver Research Topics

Disease

61	Infections 03/2022 - 06/2002
14	Viremia 09/2020 - 01/2003
11	COVID-19 01/2022 - 07/2020
10	Venezuelan Equine Encephalomyelitis 09/2020 - 08/2004
9	Virus Diseases (Viral Diseases) 01/2022 - 01/2017
9	Dengue (Dengue Fever) 07/2021 - 09/2007
9	Eastern Equine Encephalomyelitis 01/2021 - 09/2005
6	Vesicular Stomatitis 01/2021 - 01/2013
5	Zika Virus Infection 12/2019 - 01/2017
5	Chikungunya Fever 02/2017 - 07/2011
4	Alphavirus Infections 01/2022 - 11/2006
4	Arthralgia (Joint Pain) 01/2018 - 04/2011
4	St. Louis Encephalitis 08/2017 - 12/2014
3	Fever (Fevers) 01/2019 - 08/2014
2	Severe Acute Respiratory Syndrome 06/2021 - 01/2021
2	Communicable Diseases (Infectious Diseases) 10/2018 - 04/2011
2	Arthritis (Polyarthritis) 01/2018 - 09/2008
2	Exanthema (Rash) 10/2014 - 04/2011
2	Western Equine Encephalomyelitis (Encephalitis, Western Equine) 02/2010 - 11/2006
1	Disease Progression 01/2022
1	Pneumonia (Pneumonitis) 11/2021
1	Breakthrough Infections 10/2021
1	Coinfection 10/2021
1	Yellow Fever 07/2021
1	Coronavirus Infections 01/2020
1	Hydrocephalus (Hydrocephaly) 01/2019
1	Infertility (Sterility) 01/2019
1	Measles 01/2019
1	Bluetongue 08/2017
1	Fetal Death 07/2017
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 01/2017
1	Congenital Abnormalities (Deformity) 01/2017
1	Reinfection 12/2016
1	Malaria 01/2016
1	Parasitic Diseases (Parasitic Disease) 01/2016
1	Arbovirus Infections 01/2016
1	Persistent Infection 01/2015
1	Hypothermia 06/2014
1	Hyperthermia 06/2014
1	Vector Borne Diseases 07/2011
1	West Nile Fever 06/2004

Drug/Important Bio-Agent (IBA)

55	VaccinesIBA 01/2022 - 03/2006
16	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2006
15	AntibodiesIBA 01/2022 - 06/2005
13	Neutralizing AntibodiesIBA 11/2021 - 01/2005
9	Glycoproteins (Glycoprotein)IBA 12/2021 - 06/2002
8	Antiviral Agents (Antivirals)IBA 01/2022 - 09/2012
6	Attenuated VaccinesIBA 09/2020 - 09/2008
5	EnzymesIBA 02/2020 - 06/2005
5	Immunoglobulin M (IgM)IBA 02/2020 - 12/2013
4	CytokinesIBA 01/2019 - 04/2011
4	Viral RNAIBA 07/2017 - 02/2003
3	RNA (Ribonucleic Acid)IBA 10/2021 - 02/2014
3	AerosolsIBA 01/2020 - 10/2010
3	Explosive Agents (Explosives)IBA 01/2018 - 04/2011
3	ImmunosorbentsIBA 01/2015 - 06/2005
2	Alanine (L-Alanine)FDA Link 03/2022 - 01/2022
2	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 01/2018
2	Immunoglobulin G (IgG)IBA 01/2022 - 01/2018
2	Interferon Type IIBA 10/2021 - 06/2013
2	oleandrinIBA 06/2021 - 07/2020
2	Monoclonal AntibodiesIBA 01/2021 - 08/2020
2	PolyproteinsIBA 01/2018 - 01/2013
2	AntigensIBA 01/2015 - 06/2004
2	EpitopesIBA 06/2005 - 06/2002
1	LigandsIBA 01/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	Inactivated VaccinesIBA 10/2021
1	sinovac COVID-19 vaccineIBA 10/2021
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 07/2021
1	BNT162 VaccineIBA 01/2021
1	LuciferasesIBA 01/2021
1	FurinIBA 01/2021
1	Ribosomal DNA (rDNA)IBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 11/2018
1	Nucleic AcidsIBA 01/2018
1	Interferon Receptors (Interferon Receptor)IBA 01/2018
1	Complementary DNA (cDNA)IBA 02/2017
1	Auranofin (Ridaura)FDA Link 01/2017
1	Blood Substitutes (Artificial Blood)IBA 01/2017
1	3' Untranslated Regions (3' UTR)IBA 01/2017
1	Retinaldehyde (Retinal)IBA 01/2017
1	Dihydrotachysterol (AT 10)IBA 12/2014
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2014
1	Alanine Transaminase (SGPT)IBA 10/2014
1	salicylhydroxamic acid (SHAM)IBA 06/2014
1	Interleukin-6 (Interleukin 6)IBA 04/2011
1	Interleukin-12 (IL 12)IBA 04/2011
1	Green Fluorescent ProteinsIBA 07/2007
1	Biotin (Vitamin H)FDA Link 11/2006
1	Poly I-CIBA 09/2005
1	Protein Subunits (Protein Subunit)IBA 06/2004
1	GlycosaminoglycansIBA 01/2003
1	Amino Acids FDA Link 01/2003

Therapy/Procedure

6	Therapeutics 01/2022 - 07/2013
1	Transcutaneous Electric Nerve Stimulation (TENS) 01/2011
1	Injections 03/2008
1	Ambulatory Care (Outpatient Care) 12/2006